Europeans warm to pharma info

Share this article:

A Manhattan Research survey found that “nearly two in five online Europeans would like to be able to learn more about prescription drugs directly from a pharmaceutical company,” with Italians most keen on interacting with pharmas and Germans least interested.

That data point may gladden advocates of liberalizing the strict restrictions on drug company contacts with consumers that typify marketing regulations in the EU and EU member countries. The European Commission has flirted in recent years with loosening restrictions, but ratcheted back on that with a proposed policy update released in this past fall.

Europeans were less interested in getting online contests and games from pharmas than they were practical resources like disease and treatment information or condition management tools, and they were largely disinterested in visiting pharma Facebook or Twitter pages.

The findings came from Manhattan Research's Cybercitizen Health Europe 2011 survey of 3,020 adults in the UK, France, Germany, Italy and Spain.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...